Dashboard
Manage Tickers

PENPenumbra Inc

NYSE penumbrainc.com


$ 208.63 $ 2.49 (1.21 %)    

Friday, 03-May-2024 15:59:45 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 208.55
$ 209.00
$ 208.85 x 100
$ 0.00 x 0
$ 206.68 - $ 209.64
$ 180.93 - $ 348.67
311,056
na
8.18B
$ 1.10
$ 89.92
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-22-2024 12-31-2023 10-K
2 11-02-2023 09-30-2023 10-Q
3 08-01-2023 06-30-2023 10-Q
4 05-02-2023 03-31-2023 10-Q
5 02-23-2023 12-31-2022 10-K
6 11-03-2022 09-30-2022 10-Q
7 08-05-2022 06-30-2022 10-Q
8 05-03-2022 03-31-2022 10-Q
9 02-22-2022 12-31-2021 10-K
10 11-03-2021 09-30-2021 10-Q
11 08-09-2021 06-30-2021 10-Q
12 05-04-2021 03-31-2021 10-Q
13 02-23-2021 12-31-2020 10-K
14 11-02-2020 09-30-2020 10-Q
15 08-03-2020 06-30-2020 10-Q
16 05-07-2020 03-31-2020 10-Q
17 02-26-2020 12-31-2019 10-K
18 11-07-2019 09-30-2019 10-Q
19 08-06-2019 06-30-2019 10-Q
20 05-07-2019 03-31-2019 10-Q
21 02-26-2019 12-31-2018 10-K
22 11-05-2018 09-30-2018 10-Q
23 08-07-2018 06-30-2018 10-Q
24 05-08-2018 03-31-2018 10-Q
25 02-27-2018 12-31-2017 10-K
26 11-07-2017 09-30-2017 10-Q
27 08-08-2017 06-30-2017 10-Q
28 05-09-2017 03-31-2017 10-Q
29 02-28-2017 12-31-2016 10-K
30 11-03-2016 09-30-2016 10-Q
31 08-09-2016 06-30-2016 10-Q
32 05-09-2016 03-31-2016 10-Q
33 03-08-2016 12-31-2015 10-K
34 11-12-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

penumbra-announced-the-us-food-and-drug-administration-clearance-and-launch-of-lightning-flash-20-designed-to-rapidly-remove-blood-clots
Penumbra Announced The US Food And Drug Ad...
04/23/2024 13:04:52

jim-cramer-was-upset-at-this-hostile-takeover-but-they-fixed-the-situation-stocks-been-a-horse
Jim Cramer Was Upset At This Hostile Takeo...
04/09/2024 13:10:29

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he prefers Abbott Laboratories (NYSE: ABT) over

piper-sandler-reiterates-overweight-on-penumbra-maintains-290-price-target
Piper Sandler Reiterates Overweight on Pen...
04/03/2024 15:38:59

Piper Sandler analyst Matt O'Brien reiterates Penumbra (NYSE:PEN) with a Overweight and maintains $290 price target.

penumbra-stock-a-deep-dive-into-analyst-perspectives-8-ratings
Penumbra Stock: A Deep Dive Into Analyst P...
03/22/2024 14:00:52

truist-securities-maintains-buy-on-penumbra-lowers-price-target-to-280
Truist Securities Maintains Buy on Penumbr...
03/22/2024 13:22:53

Truist Securities analyst Richard Newitter maintains Penumbra (NYSE:PEN) with a Buy and lowers the price target from $290 to...

why-mercadolibre-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-fridays-mid-day-session
Why MercadoLibre Shares Are Trading Lower ...
02/23/2024 19:07:11

Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter fin...

rbc-capital-reiterates-outperform-on-penumbra-maintains-289-price-target
RBC Capital Reiterates Outperform on Penum...
02/23/2024 16:30:38

RBC Capital analyst Shagun Singh reiterates Penumbra (NYSE:PEN) with a Outperform and maintains $289 price target.

canaccord-genuity-reiterates-buy-on-penumbra-maintains-284-price-target
Canaccord Genuity Reiterates Buy on Penumb...
02/23/2024 15:05:59

Canaccord Genuity analyst William Plovanic reiterates Penumbra (NYSE:PEN) with a Buy and maintains $284 price target.

intuit-to-rally-around-14-here-are-10-top-analyst-forecasts-for-friday
Intuit To Rally Around 14%? Here Are 10 To...
02/23/2024 13:22:20

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

where-penumbra-stands-with-analysts
Where Penumbra Stands With Analysts
02/23/2024 12:00:44

jp-morgan-downgrades-penumbra-to-neutral-lowers-price-target-to-250
JP Morgan Downgrades Penumbra to Neutral, ...
02/23/2024 11:17:27

JP Morgan analyst Robbie Marcus downgrades Penumbra (NYSE:PEN) from Overweight to Neutral and lowers the price target from $...

penumbra-sees-fy24-revenue-123b-127b-vs-1267b-est
Penumbra Sees FY24 Revenue $1.23B-$1.27B V...
02/22/2024 21:52:35

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
02/22/2024 21:31:07

penumbra-q4-earnings-insights
Penumbra: Q4 Earnings Insights
02/22/2024 21:15:21

penumbra-q4-2023-adj-eps-076-beats-070-estimate-sales-28468m-miss-28656m-estimate
Penumbra Q4 2023 Adj EPS $0.76 Beats $0.70...
02/22/2024 21:14:25

Penumbra (NYSE:PEN) reported quarterly earnings of $0.76 per share which beat the analyst consensus estimate of $0.70 by 8.57 p...

earnings-scheduled-for-february-22-2024
Earnings Scheduled For February 22, 2024
02/22/2024 10:27:06

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...

earnings-preview-for-penumbra
Earnings Preview For Penumbra
02/21/2024 20:01:36

how-is-the-market-feeling-about-penumbra
How Is The Market Feeling About Penumbra?
02/13/2024 19:45:20

rbc-capital-maintains-outperform-on-penumbra-raises-price-target-to-289
RBC Capital Maintains Outperform on Penumb...
01/12/2024 19:51:47

RBC Capital analyst Shagun Singh maintains Penumbra (NYSE:PEN) with a Outperform and raises the price target from $280 to $289.

deep-dive-into-penumbra-stock-analyst-perspectives-6-ratings
Deep Dive Into Penumbra Stock: Analyst Per...
01/11/2024 19:01:12

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION